Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220031 · ClinicalTrials.gov registry record
Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Not yet
- Registry status
- 8
- Enrollment target
NCT07220031 is a clinical trial that has not yet begun recruiting, run by State University of New York - Upstate Medical University. The registered enrollment target is 8 participants.
The verdict
NCT07220031 has not yet begun recruiting, sponsored by State University of New York - Upstate Medical University.
- NOT YET RECRUITING
- Registry status
- 8 participants
- Enrollment target
Study Summary
The goal of this observational study is to determine whether a clinically relevant dose of activated charcoal raises the serum osmolality and osmolal gap in a population of healthy volunteers. Secondarily to determine whether the same dose creates a false positive result using an enzymatic assay. 1. Does a clinically relevant dose of commercially available activated charcoal raise the osmolal gap above the baseline of a healthy volunteer? 2. Does the same dose of charcoal cause a false positive enzymatic assay for ethylene glycol? Participants will be asked to consume a dose of activated charcoal and have serial blood draws for laboratory measurements.
Interventions
- DRUG Activated Charcoal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2025-11-15 |
| Est. Completion | 2026-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07220031
The ClinicalTrials.gov registry entry for NCT07220031 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Activated Charcoal is the first listed.
NCT07220031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07220031 about?
NCT07220031 is a clinical study titled "Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay". The goal of this observational study is to determine whether a clinically relevant dose of activated charcoal raises the serum osmolality and osmolal gap in a population of healthy volunteers. Secondarily to determine whether the same dose creates a false positive result using an enzymatic assay. 1...
What is the current status of trial NCT07220031?
This trial is currently not yet recruiting. The enrollment target is 8 participants. The study started on 2025-11-15. Estimated completion is 2026-05-01.
What interventions are being tested in trial NCT07220031?
The interventions under investigation include: Activated Charcoal (DRUG).
Who is sponsoring clinical trial NCT07220031?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.